Related Experiment Video
Updated: Jun 25, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Intensive therapy for diabetes through influence on innate immune system
Zhen-Zuo Li1, Jin-Bo Liu, Lin Li
1Department of Endocrinology, Qilu Hospital, Shandong University, 107#, Wenhua Xi Road, Jinan 250012, PR China.
Medical Hypotheses
|March 7, 2009
Summary
Intensive therapy and lifestyle changes benefit type 2 diabetes patients by potentially modulating the innate immune system. This may explain sustained positive effects on cardiovascular health and diabetes progression.
Area of Science:
- Endocrinology and Immunology
- Metabolic Diseases
- Clinical Trial Analysis
Background:
- Intensive therapy significantly reduces cardiovascular and microvascular events in type 2 diabetes (T2D).
- Lifestyle interventions delay diabetes onset in impaired glucose tolerance (IGT) patients.
- Mechanisms behind sustained benefits of T2D interventions remain unclear.
Purpose of the Study:
- To explore the role of the innate immune system in the sustained benefits of T2D interventions.
- To investigate if anti-inflammatory effects of therapies and exercise explain carry-over benefits.
Main Methods:
- Review of existing clinical trial data (Steno-2, China Da Qing Diabetes Prevention Study).
- Analysis of evidence linking T2D to chronic low-grade inflammation and innate immune activation.
- Consideration of anti-inflammatory properties of diabetic agents and exercise.
Main Results:
- Type 2 diabetes is associated with chronic inflammation and innate immune system activation.
- Pharmacologic agents and exercise (resistance training) possess anti-inflammatory and immunomodulatory properties.
- These effects may be independent of direct glucose or lipid lowering.
Conclusions:
- Modulation of the innate immune system may underlie sustained benefits of T2D interventions.
- Lifestyle modifications like exercise and specific therapies could offer new T2D management strategies.
- Targeting inflammation offers a potential therapeutic avenue for type 2 diabetes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...